Caris Life Sciences (CAI) Enterprise Value (2025 - 2026)

Caris Life Sciences' Enterprise Value history runs 3 years deep, the most recent figure standing at -$823.5 million for Q1 2026.

• In Q1 2026, Enterprise Value changed N/A year-over-year to -$823.5 million; the TTM figure through Mar 2026 stood at -$823.5 million (changed N/A YoY), while the FY2025 annual figure was -$800.1 million, down 1082.82% from the prior year.
• Enterprise Value for Q1 2026 stood at -$823.5 million, down from -$800.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$67.6 million in Q4 2024, with the low at -$823.5 million in Q1 2026.
• The 3-year median for Enterprise Value is -$757.0 million (2025), against an average of -$634.0 million.
• Peak annual rise in Enterprise Value reached 1082.82% in 2025, while the deepest fall reached 1082.82% in 2025.
• Caris Life Sciences' Enterprise Value stood at -$67.6 million in 2024, then sank by 1082.82% to -$800.1 million in 2025, then decreased by 2.92% to -$823.5 million in 2026.
• Business Quant data shows CAI's Enterprise Value at -$823.5 million in Q1 2026, -$800.1 million in Q4 2025, and -$757.0 million in Q3 2025.